This study has highlighted a range of potential CRC protein biomarkers and drug targets including novel markers such as ferroptosis-related proteins ACSL4, TFRC and GCLM, membrane anchor protein ANK2, RNA exosome complex components EXOSC1 and EXOSC6, and Wnt effector AMER3. Here, GCLM is linked to colorectal carcinoma.